4D Molecular Therapeutics Inc FDMT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
26.38UNCH (UNCH)
Volume
6,730
Close
26.38UNCH (UNCH)
Volume
313,121
52 week range
9.44 - 36.25
Loading...
  • Open27.21
  • Day High27.84
  • Day Low26.17
  • Prev Close26.38
  • 52 Week High36.25
  • 52 Week High Date03/27/24
  • 52 Week Low9.44
  • 52 Week Low Date10/17/23

Key Stats

  • Market Cap1.35B
  • Shares Out51.16M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta2.92
  • YTD % Change30.21

KEY STATS

  • Open27.21
  • Day High27.84
  • Day Low26.17
  • Prev Close26.38
  • 52 Week High36.25
  • 52 Week High Date03/27/24
  • 52 Week Low9.44
  • 52 Week Low Date10/17/23
  • Market Cap1.35B
  • Shares Out51.16M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta2.92
  • YTD % Change30.21

RATIOS/PROFITABILITY

  • EPS (TTM)-2.58
  • P/E (TTM)-10.24
  • Fwd P/E (NTM)-8.68
  • EBITDA (TTM)-108.467M
  • ROE (TTM)-37.40%
  • Revenue (TTM)20.723M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-486.59%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 4D Molecular Therapeutics Inc

 

Profile

MORE
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic...
John Milligan Ph.D.
Executive Chairman of the Board
David Kirn M.D.
Chief Executive Officer, Co-Founder, Director
Fariborz Kamal Ph.D.
President, Chief Operating Officer
Uneek Mehra
Chief Financial and Business Officerr, Principal Accounting Officer, Assistant Secretary
Address
5858 Horton Street #455, Emeryville
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
TARS
Tarsus Pharmaceuticals Inc
36.85+2.22+6.41%
SYRE
Spyre Therapeutics Inc
35.78-0.49-1.35%
SRRK
Scholar Rock Holding Corp
15.35+0.25+1.66%
BLTE
Belite Bio Inc
43.20+2.10+5.11%
ABCL
Abcellera Biologics Inc
4.03+0.18+4.68%